Genetic determinants of Paget's disease of bone

Annals of the New York Academy of Sciences

Volumn 1240, Issue 1, 2011, Pages 53-60

  Ralston, Stuart H ^a   Albagha, Omar M E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Genetic; Genome wide association study; Paget's disease; SNP

Indexed keywords

CALCIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PESTICIDE; PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RIN3 PROTEIN; SQSTM1 PROTEIN; TOXIN; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

ADOLESCENT DISEASE; AGE DISTRIBUTION; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CALCIUM INTAKE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENE DUPLICATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; NONHUMAN; OSTEOCLAST; PAGET BONE DISEASE; PARAMYXOVIRUS INFECTION; PREVALENCE; ZOONOSIS;

EID: 83755225692     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06228.x     Document Type: Article

References (86)

1. Kanis, J.A. 1992. Pathophysiology and Treatment of Paget's Disease of Bone. Vol. 1: 1-293. Martin Dunitz. London.
2. van Staa, T.P., P. Selby, H.G. Leufkens, et al. 2002. Incidence and natural history of Paget's disease of bone in England and Wales. J. Bone Miner. Res. 17: 465-471.
3. Detheridge, F.M., P.B. Guyer & D.J. Barker. 1982. European distribution of Paget's disease of bone. Br. Med. J. 285: 1005-1008.
4. Barker, D.J. 1984. The epidemiology of Paget's disease of bone. [Review]. Br. Med. Bull. 40: 396-400.
5. Takata, S., J. Hashimoto, K. Nakatsuka, et al. 2006. Guidelines for diagnosis and management of Paget's disease of bone in Japan. J. Bone Miner. Metab 24: 359-367.
6. Joshi, S.R., S. Ambhore, N. Butala, et al. 2006. Paget's disease from Western India. J. Assoc. Physicians India 54: 535-538.
7. Poor, G., J. Donath, B. Fornet & C. Cooper. 2006. Epidemiology of Paget's disease in Europe: the prevalence is decreasing. J. Bone Miner. Res. 21: 1545-1549.
8. Cooper, C., K. Schafheutle, E. Dennison, et al. 1999. The epidemiology of Paget's disease in Britain: is the prevalence decreasing? J. Bone Miner. Res. 14: 192-197.
9. Cundy, H.R., G. Gamble, D. Wattie, et al. 2004. Paget's disease of bone in New Zealand: continued decline in disease severity. Calcif. Tissue Int. 75: 358-364.
10. Bolland, M.J., P.C. Tong, D. Naot, et al. 2007. Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations. J. Bone Miner. Res. 22: 411-415.
11. Gennari, L., S.M. Di, D. Merlotti, et al. 2005. Prevalence of Paget's disease of bone in Italy. J. Bone Miner. Res. 20: 1845-1850.
12. Tiegs, R.D., C.M. Lohse, P.C. Wollan & L.J. Melton. 2000. Long-term trends in the incidence of Paget's disease of bone. Bone 27: 423-427.
13. Morales-Piga, A.A., J.S. Rey-Rey, J. Corres-Gonzalez, et al. 1995. Frequency and characteristics of familial aggregation of Paget's disease of bone. J. Bone Miner. Res. 10: 663-670.
14. Hocking, L.J., C.A. Herbert, R.K. Nicholls, et al. 2001. Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am. J. Hum. Genet. 69: 1055-1061.
15. Laurin, N., J.P. Brown, A. Lemainque, et al. 2001. Paget disease of bone: mapping of two loci at 5q35-qter and 5q31. Am. J. Hum. Genet. 69: 528-543.
16. Siris, E.S., R. Ottman, E. Flaster & J.L. Kelsey. 1991. Familial aggregation of Paget's disease of bone. J. Bone Miner. Res. 6: 495-500.
17. Sofaer, J.A., S.M. Holloway & A.E. Emery. 1983. A family study of Paget's disease of bone. J. Epidemiol. Community Health 37: 226-231.
18. Eekhoff, E.W., M. Karperien, D. Houtsma, et al. 2004. Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthr. Rheum. 50: 1650-1654.
19. Osterberg, P.H., R.G. Wallace, D.A. Adams, et al. 1988. Familial expansile osteolysis: a new dysplasia. J. Bone Joint Surg. Br. 70: 255-260.
20. Whyte, M.P., B.G. Mills, W.R. Reinus, et al. 2000. Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease. J. Bone Miner. Res. 15: 2330-2344.
21. Nakatsuka, K., Y. Nishizawa & S.H. Ralston. 2003. Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J. Bone Miner. Res. 18: 1381-1385.
22. Whyte, M.P. & A.E. Hughes. 2002. Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J. Bone Miner. Res. 17: 26-29.
23. Kovach, M.J., B. Waggoner, S.M. Leal, et al. 2001. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol. Genet. Metab 74: 458-475.
24. Hughes, A.E., S.H. Ralston, J. Marken, et al. 2000. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat. Genet. 24: 45-48.
25. Crockett, J.C., D.J. Mellis, K.I. Shennan, et al. 2011. Signal peptide mutations in rank prevent downstream activation of NFkappaB. J. Bone Miner. Res. 26: 1926-1938.
26. Wuyts, W., L. Van Wesenbeeck, A. Morales-Piga, et al. 2001. Evaluation of the role of RANK and OPG genes in Paget's disease of bone. Bone 28: 104-107.
27. Albagha, O.M.E., S. Wani, M.R. Visconti, et al. 2011. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat. Genet. 43: 685-689.
28. Chung, P.Y., G. Beyens, P.L. Riches, et al. 2010. Genetic variation in the TNFRSF11A gene encoding RANK is associated with susceptibility to Paget's disease of bone. J. Bone Miner. Res. 25: 2316-2329.
29. Albagha, O.M., M.R. Visconti, N. Alonso, et al. 2010. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nat. Genet. 42: 520-524.
30. Whyte, M.P., S.E. Obrecht, P.M. Finnegan, et al. 2002. Osteoprotegerin deficiency and juvenile Paget's disease. N. Engl. J. Med. 347: 175-184.
31. Cundy, T., M. Hegde, D. Naot, et al. 2002. A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum. Mol. Genet. 11: 2119-2127.
32. Middleton-Hardie, C., Q. Zhu, H. Cundy, et al. 2006. Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKL. J. Bone Miner. Res. 21: 438-445.
33. Beyens, G., A. Daroszewska, F. De Freitas, et al. 2007. Identification of sex specific effects of TNFRSF11B polymorphisms on the risk of Paget's disease of bone. Calcif. Tissue Int. 80: S42.
34. Daroszewska, A., L.J. Hocking, F.E.A. McGuigan, et al. 2004. Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of Osteoprotegerin. J. Bone Miner. Res. 19: 1506-1511.
35. Watts, G.D., J. Wymer, M.J. Kovach, et al. 2004. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36: 377-381.
36. Dai, R.M., E. Chen, D.L. Longo, et al. 1998. Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J. Biol. Chem. 273: 3562-3573.
37. Lucas, G.J., S.G. Mehta, L.J. Hocking, et al. 2006. Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. Bone 38: 280-285.
38. Laurin, N., J.P. Brown, J. Morissette & V. Raymond. 2002. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am. J. Hum. Genet. 70: 1582-1588.
39. Hocking, L.J., G.J.A. Lucas, A. Daroszewska, et al. 2002. Domain specific mutations in Sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum. Mol. Genet. 11: 2735-2739.
40. Beyens, G., H.E. Van, D.K. Van, et al. 2004. Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's disease. Calcif. Tissue Int. 75: 144-152.
41. Falchetti, A., S.M. Di, F. Marini, et al. 2009. Genetic epidemiology of Paget's disease of bone in Italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone. Calcif. Tissue Int. 84: 20-37.
42. Layfield, R. & L.J. Hocking. 2004. SQSTM1 and Paget's disease of bone. Calcif. Tissue Int. 75: 347-357.
43. Duran, A., M. Serrano, M. Leitges, et al. 2004. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev. Cell 6: 303-309.
44. Kirkin, V., T. Lamark, T. Johansen & I. Dikic. 2009. NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets. Autophagy 5: 732-733.
45. Kirkin, V., T. Lamark, Y.S. Sou, et al. 2009. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol. Cell 33: 505-516.
46. Komatsu, M., S. Waguri, M. Koike, et al. 2007. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131: 1149-1163.
47. Visconti, M.R., A.L. Langston, N. Alonso, et al. 2010. Mutations of SQSTM1 are associated with severity and clinical outcome in Paget's disease of bone. J. Bone Miner. Res. 25: 2368-2373.
48. Cavey, J.R., S.H. Ralston, P.W. Sheppard, et al. 2006. Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget's disease of bone. Calcif. Tissue Int. 78: 271-277.
49. Hiruma, Y., N. Kurihara, M.A. Subler, et al. 2008. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment. Hum. Mol. Genet. 17: 3708-3719.
50. Daroszewska, A., R.J. van't Hof, J.A. Rojas, et al. 2011. A point mutation in the ubiquitin associated domain of SQSMT1 is sufficient to cause a Paget's disease like disorder in mice. Hum. Mol. Genet. 20: 2734-2744.
51. Yoshida, H., S. Hayashi, T. Kunisada, et al. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444.
52. Yagi, M., T. Miyamoto, Y. Sawatani, et al. 2005. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202: 345-351.
53. Li, J., I. Sarosi, X.Q. Yan, et al. 2000. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl Acad. Sci. USA 97: 1566-1571.
54. Grandi, P., T. Dang, N. Pane, et al. 1997. Nup93, a vertebrate homologue of yeast Nic96p, forms a complex with a novel 205-kDa protein and is required for correct nuclear pore assembly. Mol. Biol. Cell 8: 2017-2038.
55. Zhu, G., C.J. Wu, Y. Zhao & J.D. Ashwell. 2007. Optineurin negatively regulates TNFalpha-induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr. Biol. 17: 1438-1443.
56. Shen, X., H. Ying, Y. Qiu, et al. 2011. Processing of optineurin in neuronal cells. J. Biol. Chem. 286: 3618-3629.
57. Rezaie, T., A. Child, R. Hitchings, et al. 2002. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295: 1077-1079.
58. Maruyama, H., H. Morino, H. Ito, et al. 2010. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465: 223-226.
59. Lucas, G., P. Riches, L. Hocking, et al. 2008. Identification of a major locus for Paget disease on chromosome 10p13 in families of British descent. J. Bone Miner. Res. 23: 58-63.
60. Kajiho, H., K. Saito, K. Tsujita, et al. 2003. RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway. J. Cell Sci. 116: 4159-4168.
61. Salomoni, P. & P.P. Pandolfi. 2002. The role of PML in tumor suppression. Cell 108: 165-170.
62. Lin, H.K., S. Bergmann & P.P. Pandolfi. 2004. Cytoplasmic PML function in TGF-beta signalling. Nature 431: 205-211.
63. Smits, P., A.D. Bolton, V. Funari, et al. 2010. Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. N. Engl. J. Med. 362: 206-216.
64. Hennies, H.C., U. Kornak, H. Zhang, et al. 2008. Gerodermia osteodysplastica is caused by mutations in SCYL1BP1, a Rab-6 interacting golgin. Nat. Genet. 40: 1410-1412.
65. Donath, J., G. Speer, G. Poor, et al. 2004. Vitamin D receptor, oestrogen receptor-alpha and calcium-sensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone. Rheumatology (Oxford) 43: 692-695.
66. Beyens, G., A. Daroszewska, F.F. de Freitas, et al. 2007. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone. J. Bone Miner. Res. 22: 1062-1071.
67. Chung, P.Y., G. Beyens, F.F. de Freitas, et al. 2011. Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms. Mol. Genet. Metab 103: 287-292.
68. Corral-Gudino, L., J. Del Pino-Montes, J. Garcia-Aparicio, et al. 2010. Paget's disease of bone is not associated with common polymorphisms in interleukin-6, interleukin-8 and tumor necrosis factor alpha genes. Cytokine 52: 146-150.
69. Corral-Gudino, L., J. Del Pino-Montes, J. Garcia-Aparicio, et al. 2006. -511 C/T IL1B gene polymorphism is associated to resistance to bisphosphonates treatment in Paget disease of bone. Bone 38: 589-594.
70. Rebel, A., K. Malkani, M. Basle, et al. 1974. Ultrastructural characteristics of osteoclasts in Paget's disease. Rev. Rhum. Mal. Osteoartic. 41: 767-771.
71. Gordon, M.T., A.P. Mee, D.C. Anderson & P.T. Sharpe. 1992. Canine distemper transcripts sequenced from pagetic bone. Bone Miner. 19: 159-174.
72. Gordon, M.T., D.C. Anderson & P.T. Sharpe. 1991. Canine distemper virus localised in bone cells of patients with Paget's disease. Bone 12: 195-201.
73. Mee, A.P., J.A. Dixon, J.A. Hoyland, et al. 1998. Detection of Canine Distemper Virus in 100% of Paget's disease samples by in situ-reverse transcriptase polymerase chain reaction. Bone 23: 171-175.
74. Birch, M.A., W. Taylor, W.D. Fraser, et al. 1994. Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone. J. Bone Miner. Res. 9: 11-16.
75. Helfrich, M.H., R.P. Hobson, P.S. Grabowski, et al. 2000. A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J. Bone Miner. Res. 15: 2315-2329.
76. Nuovo, M.A., G.J. Nuovo, P. MacConnell, et al. 1992. In situ analysis of Paget's disease of bone for measles-specific PCR-amplified cDNA. Diagn. Mol. Pathol. 1: 256-265.
77. Ooi, C.G., C.A. Walsh, J.A. Gallagher & W.D. Fraser. 2000. Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone. Bone 27: 417-421.
78. Ralston, S.H., F.S. DiGiovine, S.J. Gallacher, et al. 1991. Failure to detect paramyxovirus sequences in Paget's disease of bone using the polymerase chain reaction. J. Bone Miner. Res. 6: 1243-1248.
79. Matthews, B.G., M.A. Afzal, P.D. Minor, et al. 2008. Failure to detect measles virus RNA in bone cells from patients with Paget's disease. J. Clin. Endocrinol. Metab. 93: 1398-1401.
80. Ralston, S.H., M.A. Afzal, M.H. Helfrich, et al. 2007. Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone. J. Bone Miner. Res. 22: 569-577.
81. Selby, P.L., M. Davies & A.P. Mee. 2006. Canine distemper virus induces human osteoclastogenesis through NF-kappaB and sequestosome 1/P62 activation. J. Bone Miner. Res. 21: 1750-1756.
82. Kurihara, N., H. Zhou, S.V. Reddy, et al. 2006. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice. J. Bone Miner. Res. 21: 446-455.
83. Siris, E.S. 1994. Epidemiological aspects of Paget's disease: family history and relationship to other medical conditions. Semin. Arthritis Rheum. 23: 222-225.
84. Solomon, L.R. 1979. Billiard-player's fingers: an unusual case of Paget's disease of bone. Br. Med. J. 1: 931.
85. Lopez-Abente, G., A. Morales-Piga, A. Elena-Ibanez, et al. 1997. Cattle, pets, and Paget's disease of bone. Epidemiology 8: 247-251.
86. Lever, J.H. 2002. Paget's disease of bone in Lancashire and arsenic pesticide in cotton mill wastewater: a speculative hypothesis. Bone 31: 434-436.